Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

KRTAP10 Inhibitors

KRTAP10 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the KRTAP10 proteins. KRTAP, or keratin-associated proteins, are crucial components of the hair follicle structure, where they form the cross-linking matrix that binds keratin fibers. KRTAP10 refers to a subset of these proteins involved in the formation and maintenance of this structural integrity. The inhibitors in this class disrupt the normal interaction and functionality of KRTAP10 proteins, affecting the assembly of keratin filaments. These inhibitors work at the molecular level by binding to specific regions of the KRTAP10 proteins, altering their conformation or preventing their interaction with keratin or other associated proteins, which results in changes to the overall structural dynamics of keratin matrices.

Chemically, KRTAP10 inhibitors often belong to a diverse range of molecular scaffolds, depending on their specific mechanism of action. Some may function through small-molecule inhibition, while others might involve larger, more complex biomolecules. Their molecular structure typically includes functional groups designed to interact with the protein's active or binding sites. These inhibitors can be designed to have high specificity for KRTAP10 over other keratin-associated proteins, which is critical to avoid non-specific effects on other keratin-forming processes. The precise mechanism of inhibition can vary, with some compounds acting allosterically by changing the protein's shape and others competitively, directly blocking the interaction of KRTAP10 with keratin fibers. Research in this area focuses on understanding the molecular architecture of these inhibitors and how their binding kinetics influence the assembly and function of keratin structures.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D may inhibit KRTAP10 expression by intercalating into DNA, blocking RNA synthesis and affecting transcription of KRTAP10.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide might inhibit KRTAP10 expression by blocking protein synthesis, thereby reducing the production of KRTAP10 protein.

Chromomycin A3

7059-24-7sc-200907
10 mg
$255.00
(1)

Actinomycin C could potentially inhibit KRTAP10 expression similarly to Actinomycin D, by interfering with RNA synthesis.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

Rifampicin may inhibit KRTAP10 expression by targeting bacterial-like RNA polymerase, potentially affecting the transcription of KRTAP10.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$163.00
$316.00
436
(1)

Puromycin might inhibit KRTAP10 expression by prematurely terminating protein synthesis, thereby reducing KRTAP10 production.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Anisomycin has been suggested to inhibit KRTAP10 expression by inhibiting protein synthesis at the translational level, affecting KRTAP10 production.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin may inhibit KRTAP10 expression by intercalating into DNA and impacting transcription, reducing the synthesis of KRTAP10.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposide could potentially inhibit KRTAP10 expression by affecting topoisomerase II activity, influencing DNA transcription and KRTAP10 synthesis.

Blasticidin S Hydrochloride

3513-03-9sc-204655A
sc-204655
25 mg
100 mg
$360.00
$475.00
20
(2)

Blasticidin S may inhibit KRTAP10 expression by interfering with protein synthesis, potentially reducing the production of KRTAP10.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

Mitomycin C might inhibit KRTAP10 expression by crosslinking DNA, affecting transcription and potentially reducing KRTAP10 synthesis.